Endo Pharmaceuticals was issued a subpoena by the Department of Health and Human Services regarding the promotion of its post-shingles pain patch Lidoderm, requesting documents from 1999 to the present related to the company’s knowledge of off-label uses for the treatment.
Endo Pharmaceuticals was issued a subpoena by the Department of Health and Human Services regarding the promotion of its post-shingles pain patch Lidoderm, requesting documents from 1999 to the present related to the company’s knowledge of off-label uses for the treatment.
From the March 01, 2007 Issue of MM+M - Medical Marketing and Media
Get the most out of 
Register for free and enjoy unlimited access to:
